Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 230-983-3 | CAS number: 7392-19-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- The study was conducted in 1979.
- Reliability:
- 2 (reliable with restrictions)
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Induction: Days 0 – 20.
On Day 0, 0.1 mL of the test material undiluted and at progressively diluted solutions were applied to an area measuring 8 cm2 on the clipped flank skin of six guinea pigs per concentration groups.
The applications were repeated daily for three weeks, or done 5 times weekly during four weeks, always using the same skin site. Te application site was left uncovered. If very strong skin reactions were provoked then the application site was changed.
Challenge: Days 21 to 35.
To determine whether or not contact sensitisation was induced, all groups of guinea pigs previously treated for 21 days, as well as 6 to 8 untreated or only with the vehicle pre-treated controls are tested on Days 21 and 35 on the contralateral flank with the test material at the minimal irritating and some lower concentrations. The minimal irritating concentration of each material is used in order to confirm the biological activity determined before starting the induction (Day -1) and to exclude false results based on instability of the test materials. These tests are performed by applying with a pipette 0.025 mL of each concentration to skin areas measuring 2 cm2, the reactions being read after 24, 48 and / or 72 hours. This procedure enables to determine the minimal sensitising concentration necessary for inducing allergic contact hyper-sensitivity and the minimal eliciting concentration necessary to cause a positive reaction.
The test material is considered allergenic at a concentration when at least one out of the eight animals of this concentration group shows positive reactions with non-irritant concentrations used for challenge, i.d. its threshold concentration causing skin-reactions is shifted to the lower part of the concentration range used for challenge. - GLP compliance:
- no
- Remarks:
- Study pre-dates GLP.
- Type of study:
- open epicutaneous test
- Species:
- guinea pig
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals and environmental conditions:
- No data
- Route:
- epicutaneous, open
- Vehicle:
- other: Ethanol
- Concentration / amount:
- 3, 10, 30 and 100 %
- Route:
- epicutaneous, open
- Vehicle:
- other: Ethanol
- Concentration / amount:
- 3, 10, 30 and 100 %
- No. of animals per dose:
- 6 animals / dose
- Details on study design:
- Induction: Days 0 – 20.
On Day 0, 0.1 mL of the test material undiluted and at progressively diluted solutions were applied to an area measuring 8 cm2 on the clipped flank skin of six guinea pigs per concentration groups.
The applications were repeated daily for three weeks, or done 5 times weekly during four weeks, always using the same skin site. Te application site was left uncovered. If very strong skin reactions were provoked then the application site was changed.
Challenge: Days 21 to 35.
To determine whether or not contact sensitisation was induced, all groups of guinea pigs previously treated for 21 days, as well as 6 to 8 untreated or only with the vehicle pre-treated controls are tested on Days 21 and 35 on the contralateral flank with the test material at the minimal irritating and some lower concentrations. The minimal irritating concentration of each material is used in order to confirm the biological activity determined before starting the induction (Day -1) and to exclude false results based on instability of the test materials. These tests are performed by applying with a pipette 0.025 mL of each concentration to skin areas measuring 2 cm2, the reactions being read after 24, 48 and / or 72 hours. This procedure enables to determine the minimal sensitising concentration necessary for inducing allergic contact hyper-sensitivity and the minimal eliciting concentration necessary to cause a positive reaction.
The test material is considered allergenic at a concentration when at least one out of the eight animals of this concentration group shows positive reactions with non-irritant concentrations used for challenge, i.d. its threshold concentration causing skin-reactions is shifted to the lower part of the concentration range used for challenge. - Reading:
- 1st reading
- Hours after challenge:
- 504
- Group:
- test chemical
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 6
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 504.0. Group: test group. Dose level: 100 %. No with. + reactions: 0.0. Total no. in groups: 6.0.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test substance does not sensitise the guinea pig.
- Executive summary:
The test substance was assessed for skin sensitisation potential using an open epicutaneous test on guinea pigs. The test substance was not sensitising under the conditions of the test.
Reference
Capacity to cause allergic sensitisation
After daily applications over 3 weeks Concentration % |
Sensitisation rate number of animals Positive / total |
|
Day 21 |
Day 35 |
|
100 |
0 / 6 |
0 / 6 |
30 |
0 / 6 |
0 / 6 |
10 |
0 / 6 |
0 / 6 |
3 |
0 / 6 |
0 / 6 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Induction on Day 0 using 0.1 mL of the test material undiluted and at progressively diluted solutions was applied to an area measuring 8 cm2 on the clipped flank skin of six guinea pigs per concentration groups. The applications were repeated always using the same skin site.
To determine whether or not contact sensitisation was induced, all groups of guinea pigs previously treated for 21 days were tested on Days 21 and 35 on the contralateral flank with the test material at the minimal irritating and some lower concentrations using 0.025 mL of each concentration to skin areas measuring 2 cm2.
There were no skin sensitisation reactions at any concentration tested.
The result of the in vitro DPRA assay when used as part of anintegrated approach for testing and assessment (IATA) with the in vitro KeratinoSens™assay, indicate that these congruent results give a good prediction of the sensitizer hazard particularly when predicting human data.
In this case, the in vitro DPRA assay, in vitro KeratinoSens™assay along with the in vivo guinea pig data indicates a lack of skin sensitisation and hence, no classification is warranted for Limetol.
Migrated from Short description of key information:
The test substance was assessed for skin sensitisation potential using an open epicutaneous test on guinea pigs. The test substance was not sensitising under the conditions of the test.
Justification for selection of skin sensitisation endpoint:
The study was conducted on the target substance in vivo.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
A skin sensitiser is defined as a substance that will lead to an allergic response following skin contact. Sensitisation includes two phases,
The induction of specialised immunological memory in an individual by exposure to an allergen and elicitation where the production of cell-mediated or antibody mediated allergic response by exposure of a sensitised individual to an allergen.
For skin sensitisation, an induction phase is required in which the immune system learns to react; clinical symptoms can then arise when subsequent exposure is sufficient to elicit a visible skin reaction (elicitation phase). Lower levels are usually required for elicitation than are required for induction.
Substances shall be classified as a Category 1 skin sensitiser if there is evidence in humans that the substance can lead to sensitisation by skin contact in a substantial number of persons, or if there are positive results form an appropriate animal test. When an adjuvant type guinea pig test method for skin sensitisation is used, a response of at least 30 % of the animals is considered positive. For a non-adjuvant guinea pig test a response of a t least 15 % of the animals is considered positive.
No positive skin sensitisation reactions were elicited during the study and the test substance is therefore not classified as a skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
